These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35970875)

  • 1. Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant.
    Baranwal A; Byun J; Ritz E; Kadanagowd A; Murphy D; Marinovic DA; Wang D; Okwuosa T; Katz D; Varma A; Nathan S; Ustun C
    Bone Marrow Transplant; 2022 Oct; 57(10):1632-1634. PubMed ID: 35970875
    [No Abstract]   [Full Text] [Related]  

  • 2. High risk of acute pulmonary toxicity with both myeloablative and non-myeloablative total body irradiation-based conditioning for allogeneic stem cell transplantation.
    Patel P; Dillon M; Niedzwiecki D; Crowell KA; Horwitz ME; Wang E; Kelsey CR
    Bone Marrow Transplant; 2024 Jan; 59(1):150-152. PubMed ID: 37923832
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
    Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Total Body Irradiation-based Versus Chemotherapy-based Conditionings for Early Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Children With ALL.
    Yalcin K; Pehlivan B; Celen S; Bas EG; Kabakci C; Pashayev D; Daloglu H; Zhumatayev S; Uygun V; Karasu GT; Hazar V; Yesilipek A
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):266-270. PubMed ID: 33625092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pubertal outcomes of children transplanted with allogeneic stem cells after myeloablative total body irradiation or busulfan: Influence of age and sex is confirmed, while a role of chronic graft-versus-host disease in delayed puberty onset is revealed.
    Weinhard S; Wiedemann A; Leheup B; Dalle JH; Lebon Labich B; Pochon C
    Pediatr Transplant; 2020 Sep; 24(6):e13773. PubMed ID: 32701220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute graft-vs-host disease: pathobiology and management.
    Goker H; Haznedaroglu IC; Chao NJ
    Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation.
    Czyz A; Labopin M; Giebel S; Socié G; Apperley J; Volin L; Reményi P; Yakoub-Agha I; Orchard K; Michallet M; Stuhler G; Chaganti S; Murray M; Aljurf M; Bloor A; Passweg J; Finke J; Mohty M; Nagler A
    Am J Hematol; 2018 Jun; 93(6):778-785. PubMed ID: 29574915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.
    Herr MM; Curtis RE; Tucker MA; Tecca HR; Engels EA; Cahoon EK; Battiwalla M; Buchbinder D; Flowers ME; Brazauskas R; Shaw BE; Morton LM
    J Am Acad Dermatol; 2020 Sep; 83(3):762-772. PubMed ID: 31654664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.
    Motohashi K; Fujisawa S; Onizuka M; Kako S; Sakaida E; Shono K; Tatara R; Doki N; Mori T; Sakura T; Aotsuka N; Fuji E; Tomita N; Kawai N; Saitoh T; Usuki K; Taguchi J; Watanabe R; Kobayashi S; Yano S; Kanamori H; Takahashi S; Okamoto S
    Bone Marrow Transplant; 2015 Nov; 50(11):1476-9. PubMed ID: 26191948
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI.
    Nagler A; Labopin M; Dholaria B; Niittyvuopio R; Maertens J; Poiré X; Cornelissen J; Reményi P; Bourhis JH; Beguin Y; Malladi R; Kerre T; Schroyens W; Savani BN; Mohty M
    Blood Adv; 2019 Jul; 3(13):1950-1960. PubMed ID: 31262738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):345-355.e7. PubMed ID: 31014757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
    Holter-Chakrabarty JL; Pierson N; Zhang MJ; Zhu X; Akpek G; Aljurf MD; Artz AS; Baron F; Bredeson CN; Dvorak CC; Epstein RB; Lazarus HM; Olsson RF; Selby GB; Williams KM; Cooke KR; Pasquini MC; McCarthy PL
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1251-7. PubMed ID: 25840335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.
    Anand A; Anandi P; Jain NA; Lu K; Dunavin N; Hourigan CS; Le RQ; Chokshi PD; Ito S; Stroncek DF; Sabatino M; Barrett AJ; Battiwalla M
    Support Care Cancer; 2016 Feb; 24(2):815-822. PubMed ID: 26190358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant.
    Malone FR; Leisenring WM; Storer BE; Lawler R; Stern JM; Aker SN; Bouvier ME; Martin PJ; Batchelder AL; Schoch HG; McDonald GB
    Bone Marrow Transplant; 2007 Oct; 40(8):765-72. PubMed ID: 17700598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
    Speziali C; Daly A; Abuhaleeqa M; Nitta J; Abou Mourad Y; Seftel MD; Paulson K
    Leuk Lymphoma; 2019 Mar; 60(3):639-648. PubMed ID: 30160568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
    Friend BD; Bailey-Olson M; Melton A; Shimano KA; Kharbanda S; Higham C; Winestone LE; Huang J; Stieglitz E; Dvorak CC
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28079. PubMed ID: 31724815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis.
    Khimani F; Dutta M; Faramand R; Nishihori T; Perez AP; Dean E; Nieder M; Perez L; Mishra A; Elmariah H; Davila M; Ochoa L; Alsina M; Lazaryan A; Bejanyan N; Hansen D; Jain M; Locke F; Liu H; Pidala J; Shah B; Mhaskar R
    Transplant Cell Ther; 2021 Jul; 27(7):620.e1-620.e9. PubMed ID: 33798768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.
    Harada K; Yanada M; Machida S; Kanamori H; Onizuka M; Ozawa Y; Kobayashi H; Sawa M; Katayama Y; Ohashi K; Kanda J; Ichinohe T; Atsuta Y; Yano S
    Leuk Lymphoma; 2019 Jun; 60(6):1493-1502. PubMed ID: 30457400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.